Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-053030

VP, Chief Accounting Officer gave up 15,603 shares (to pay taxes)

  • VP, Chief Accounting Officer acquired 45,115 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Peraza Lisa VP, Chief Accounting Officer 2023-07-25 Option exercise +42,631 67,941 D
Peraza Lisa VP, Chief Accounting Officer 2023-07-25 Shares withheld for taxes −14,743 $1.51 $22,262 53,198 D
Peraza Lisa VP, Chief Accounting Officer 2023-10-13 Option exercise +552 53,750 D
Peraza Lisa VP, Chief Accounting Officer 2023-10-13 Option exercise +1,932 55,682 D
Peraza Lisa VP, Chief Accounting Officer 2023-10-13 Shares withheld for taxes −860 $0.72 $619 54,822 D
Derivatives
Peraza Lisa VP, Chief Accounting Officer 2023-07-25 Option exercise · Performance Stock Units −42,631 0 D
Peraza Lisa VP, Chief Accounting Officer 2023-10-13 Option exercise · Restricted Stock Units −552 2,208 D
Peraza Lisa VP, Chief Accounting Officer 2023-10-13 Option exercise · Restricted Stock Units −1,932 7,964 D
Loading xslF345X05/doc4.xml…